Bench Test for the Detection of Bacterial Contamination in Platelet Concentrates Using Rapid and Cultural Detection

Tanja Vollmer1, Cornelius Knabbe1, Wolf-Jochen Geilenkeuser2

  • 1Institute for Laboratory and Transfusion Medicine, Heart and Diabetes Center North Rhine Westphalia, Bad Oeynhausen, Germany.

Abstract

Insights

This study evaluated rapid and culture methods for detecting bacterial contamination in platelet concentrates (PCs). BactiFlow showed 100% sensitivity, outperforming NAT at lower bacterial levels, while culture methods achieved perfect results.

Area of Science:

  • Transfusion Medicine
  • Microbiology
  • Quality Assurance

Background:

  • Bacterial contamination of platelet concentrates (PCs) is a primary infectious risk in transfusion therapy.
  • Existing rapid and culture screening methods require external performance validation.
  • This study presents results from collaborative trials using an external quality assessment program (EQAP).

Purpose of the Study:

  • To evaluate the performance of current rapid and cultural screening methods for bacterial detection in platelet concentrates.
  • To assess the analytical sensitivity and specificity of these methods under controlled conditions.
  • To validate an external quality assessment program (EQAP) for bacterial screening methods.

Main Methods:

  • Three modules were used: rapid methods, culture methods, and bacterial identification.
  • Sample sets included negative and positive samples with stabilized bacterial counts (10^3-10^5 CFU/ml).
  • Testing timeframes were limited: 6 hours for rapid methods and 7 days for culture methods.

Main Results:

  • Both rapid methods correctly identified negative samples.
  • BactiFlow demonstrated 100% sensitivity, while NAT showed 86.6-93.8% sensitivity at 10^3 CFU/ml.
  • Culture methods (modules 2 and 3) achieved 100% diagnostic sensitivity and specificity across all trials.

Conclusions:

  • The EQAP facilitates verification of bacterial detection systems' analytical sensitivity.
  • The provided matrix-equivalent, ready-to-use samples support testing of both rapid and culture methods.
  • This proficiency panel enables reliable performance evaluation under routine conditions.